top of page
Search

Women's Hormone Therapy: What the Research Actually Shows (and Why It Matters)

Updated: Apr 13


For decades, women's hormonal health was treated as a binary: you either endure the symptoms of menopause, or you take hormone replacement therapy and accept an overstated risk. The landscape has changed substantially. A generation of research—including critical reanalysis of the Women's Health Initiative data—has clarified both the benefits and the actual risk profile of hormone therapy for women, and modern precision medicine approaches have made personalized, evidence-informed hormone optimization accessible in ways it has never been before.


The Hormonal Shifts Women Experience

Women's hormonal health is not a single event—it is a continuum. Perimenopause, which can begin as early as the mid-30s and typically spans 4–10 years before the final menstrual period, involves fluctuating and ultimately declining estrogen and progesterone. Testosterone, often overlooked in women's health conversations, also declines significantly through this period and contributes to reduced libido, energy, muscle mass, and cognitive sharpness. Post-menopause, estrogen and progesterone production from the ovaries ceases, with significant downstream effects on bone density, cardiovascular health, cognitive function, vaginal and urinary tissue health, and metabolic function.


Common Symptoms of Hormonal Decline in Women

The symptoms of declining female hormones are wide-ranging and frequently dismissed or undertreated. They include vasomotor symptoms such as hot flashes and night sweats, sleep disturbance, mood changes including anxiety and depression, cognitive changes and brain fog, reduced libido and sexual dysfunction, genitourinary syndrome of menopause (vaginal dryness, urinary urgency, recurrent infections), accelerated loss of muscle mass and bone density, increased visceral fat accumulation, and skin changes. Many women are told these symptoms are 'normal' and simply part of aging. They are normal in the sense that they are common—but they are not inevitable, and they are not untreatable.


What the Research Actually Shows

The Women's Health Initiative (WHI) study, published in 2002, caused widespread abandonment of hormone therapy based on reported risks of breast cancer and cardiovascular events. Subsequent analysis revealed critical confounders: the study population was older (average age 63), many years post-menopause, and the formulations used were not representative of modern bioidentical hormone therapy. A landmark 2017 re-analysis published in Climacteric, along with the Menopause Society's updated position statement, confirmed that for healthy women under 60 or within 10 years of menopause onset, the benefits of hormone therapy substantially outweigh the risks—including for cardiovascular protection, bone density, cognitive health, and quality of life.


The Role of Testosterone in Women's Health

Testosterone is the most abundant biologically active sex hormone in women throughout their lifespan—a fact that surprises many. Research published in the Journal of Clinical Endocrinology & Metabolism demonstrates that low testosterone in women is associated with reduced libido, impaired arousal, diminished energy, decreased muscle mass, and depressed mood. Low-dose testosterone therapy in women has strong evidence for improving sexual function and emerging evidence for benefits in mood, cognition, and muscle preservation—particularly relevant for active women pursuing a strength-first approach to aging.


Personalized Women's Hormone Therapy at OHI

At Oak Health Institute, women's hormone therapy begins with a comprehensive evaluation: detailed hormonal labs including estradiol, progesterone, total and free testosterone, SHBG, thyroid panel, and DHEA-S, combined with a thorough symptom inventory and health history review. Dr. Frank J. Welch then develops a personalized protocol using bioidentical hormones calibrated to your individual biology. We integrate hormone therapy with the broader OHI framework—addressing body composition, strength, nutrition, and sexual health as a coordinated system. All care is delivered via telemedicine with the discretion and clinical depth that this area of medicine deserves.


If you are experiencing symptoms that may be related to hormonal changes—whether you are in perimenopause, menopause, or simply noticing changes in your energy, body composition, or wellbeing—we invite you to schedule a consultation. You deserve care that takes your symptoms seriously and addresses them with both clinical rigor and genuine respect.

 
 
 

Comments


O

Physician-led. Strength first. Data-driven. Healthspan, built deliberately.
PROTECT LEAN MASS 

VISIT

19 W Hargett St, Suite 600

Raleigh, NC 27601

Contact

Start your assessment

STAY IN TOUCH

Healthspan notes from Dr. Welch and the OHI team. No noise.

 ©2026 OAK HEALTH INSTITUTE
PRIVACY·TERMS·HIPAA
bottom of page